BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24724588)

  • 21. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD.
    Du J; Wilson PD
    Am J Physiol; 1995 Aug; 269(2 Pt 1):C487-95. PubMed ID: 7653531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
    Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
    Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β3 adrenergic receptor as potential therapeutic target in ADPKD.
    Schena G; Carmosino M; Chiurlia S; Onuchic L; Mastropasqua M; Maiorano E; Schena FP; Caplan MJ
    Physiol Rep; 2021 Oct; 9(20):e15058. PubMed ID: 34676684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver cyst cytokines promote endothelial cell proliferation and development.
    Brodsky KS; McWilliams RR; Amura CR; Barry NP; Doctor RB
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1155-65. PubMed ID: 19596832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Chandra AN; Saravanabavan S; Rangan GK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ; Qin F; Zhu L
    J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures.
    Elberg G; Guruswamy S; Logan CJ; Chen L; Turman MA
    Cell Tissue Res; 2008 Feb; 331(2):495-508. PubMed ID: 18004594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.
    Wallace DP; Quante MT; Reif GA; Nivens E; Ahmed F; Hempson SJ; Blanco G; Yamaguchi T
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1463-71. PubMed ID: 18753297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
    Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
    Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
    Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADPKD cell proliferation and Cl
    Reif GA; Wallace DP
    Methods Cell Biol; 2019; 153():69-92. PubMed ID: 31395385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease.
    Park EY; Kim BH; Lee EJ; Chang E; Kim DW; Choi SY; Park JH
    J Biol Chem; 2014 Mar; 289(13):9254-62. PubMed ID: 24515114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.
    Terryn S; Ho A; Beauwens R; Devuyst O
    Biochim Biophys Acta; 2011 Oct; 1812(10):1314-21. PubMed ID: 21255645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug therapy for polycystic kidney disease: a review and perspective.
    Aguiari G; Catizone L; Del Senno L
    Am J Nephrol; 2013; 37(2):175-82. PubMed ID: 23428809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to inhibit cyst formation in ADPKD.
    Calvet JP
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1205-11. PubMed ID: 18434615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
    Wilson PD; Hreniuk D; Gabow PA
    J Cell Physiol; 1992 Feb; 150(2):360-9. PubMed ID: 1734038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic kidney disease: pathogenesis and potential therapies.
    Takiar V; Caplan MJ
    Biochim Biophys Acta; 2011 Oct; 1812(10):1337-43. PubMed ID: 21146605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.